Overcoming cancer drug resistance with nanoparticles

January 20, 2012

One of the ways in which cancer cells evade anticancer therapy is by producing a protein that pumps drugs out of the cell before these compounds can exert their cell-killing effects. A research team at Northwestern University has found that biocompatible iron oxide-titanium dioxide nanoparticles can bypass this pump and enable DNA-damaging anticancer drugs to reach the cell nucleus.

Gayle Woloschak, a member of the Northwestern University Center for Cancer Nanotechnology Excellence, led the research team that developed this nanoparticle. She and her collaborators reported their findings in the journal Cancer Research.

The goal of this work was two-fold: identify a nanoparticle that would overcome pump-related drug resistance which could simultaneously serve as a tumor imaging agent. The researchers chose a nanoparticle with an iron oxide core surrounded by a titanium dioxide shell. The iron oxide core serves as a powerful (MRI) contrast agent, while the shell can bind to anticancer agents such as doxorubicin through a chemical bond that will break in the acidic conditions inside a cancer cell.

The investigators treated drug-resistant with a doxorubicin-loaded nanoparticle and showed that the nanoparticle was readily transported into the cells. More importantly, the nanoparticles released their drug payload, enabling doxorubicin to reach the . Doxorubicin kills cells through a process that involves binding to DNA in the nucleus. When compared to doxorubicin alone, the accumulated up to 6 times more drug then when administered using the nanoparticle-drug combination. Interestingly, the researchers found that when they co-administered even empty nanoparticles (no doxorubicin) with transferrin, a molecule involved in iron transport, they saw increased cell uptake of transferrin. This observation is important since many research groups are developing nanoparticles that incorporate transferrin on the surface to stimulate cell uptake. In this scenario, it could be beneficial to co-treat with this type of empty particle.

This work, which is detailed in a paper titled, "Nanocarriers enhance doxorubicin uptake in drug-resistant ovarian cancer cells," was supported in part by the NCI Alliance for Nanotechnology in Cancer, a comprehensive initiative designed to accelerate the application of nanotechnology to the prevention, diagnosis, and treatment of cancer. An abstract of this paper is available at the journal's website.

Explore further: Two-In-One Punch Knocks Out Drug Resistant Cancer Cells

Related Stories

Two-In-One Punch Knocks Out Drug Resistant Cancer Cells

November 4, 2009

(PhysOrg.com) -- Cancer cells, like bacteria, can develop resistance to drug therapy, leading to relapse of disease. One approach showing promise in overcoming multidrug resistance in tumors is to combine two different anticancer ...

Double-Duty Nanoparticles Overcome Drug Resistance in Tumors

June 14, 2007

Cancer cells, like bacteria, can develop resistance to drug therapy. In fact, research suggests strongly that multidrug resistant cancer cells that remain alive after chemotherapy are responsible for the reappearance of tumors ...

Therapeutic nanoparticles targeted to radiation treated tumors

March 28, 2011

Radiation and chemotherapy are common partners in anticancer therapy for solid tumors, but too often, the combined side effects associated with each mode of therapy can limit how aggressively oncologists can treat their patients. ...

New Nanoparticles for Targeting Tumors

March 27, 2008

As a wide variety of nanoparticles continue to demonstrate their ability to improve the delivery of imaging agents and drugs to tumors, nanoparticle researchers have turned their attention to the challenge of systematically ...

Recommended for you

Graphene's sleeping superconductivity awakens

January 19, 2017

Researchers have found a way to trigger the innate, but previously hidden, ability of graphene to act as a superconductor - meaning that it can be made to carry an electrical current with zero resistance.

New low-cost technique converts bulk alloys to oxide nanowires

January 19, 2017

A simple technique for producing oxide nanowires directly from bulk materials could dramatically lower the cost of producing the one-dimensional (1D) nanostructures. That could open the door for a broad range of uses in lightweight ...

Creating atomic scale nanoribbons

January 19, 2017

Silicon crystals are the semiconductors most commonly used to make transistors, which are critical electronic components used to carry out logic operations in computing. However, as faster and more powerful processors are ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.